XML 17 R4.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($)
shares in Thousands, $ in Thousands
 3 Months Ended 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Mar. 31, 2026
Mar. 31, 2025
Condensed Consolidated Statements of Operations and Comprehensive Loss        
Revenue     $ 100 $ 200
Operating expenses:        
Research and development $ 3,254 $ 1,906 11,084 5,088
General and administrative 5,111 2,973 12,777 8,516
Total operating expenses 8,365 4,879 23,861 13,604
Operating loss (8,365) (4,879) (23,761) (13,404)
Other income (expense):        
Interest income 657 72 1,417 358
Interest expense (22) (54) (99) (168)
Total other income (expense) 635 18 1,318 190
Net loss (7,730) (4,861) (22,443) (13,214)
Other comprehensive loss - unrealized loss on on debt securities (31)   (21)  
Comprehensive loss $ (7,761) $ (4,861) $ (22,464) $ (13,214)
Loss per common share - basic $ (0.06) $ (0.49) $ (0.25) $ (1.44)
Loss per common share - diluted $ (0.06) $ (0.49) $ (0.25) $ (1.44)
Weighted-average common shares outstanding - basic 119,600 9,862 90,295 9,202
Weighted-average common shares outstanding - diluted 119,600 9,862 90,295 9,202